Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance
出版年份 2011 全文链接
标题
Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance
作者
关键词
-
出版物
BRITISH JOURNAL OF HAEMATOLOGY
Volume 155, Issue 1, Pages 53-64
出版商
Wiley
发表日期
2011-07-12
DOI
10.1111/j.1365-2141.2011.08794.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9
- (2011) Andrea G. S. Buggins et al. BRITISH JOURNAL OF HAEMATOLOGY
- Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia
- (2010) M. Buchner et al. BLOOD
- The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies
- (2010) Maike Buchner et al. BRITISH JOURNAL OF HAEMATOLOGY
- Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non-Hodgkin's Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup Study
- (2010) Marinus H.J. van Oers et al. JOURNAL OF CLINICAL ONCOLOGY
- Antigenic Modulation and Rituximab Resistance
- (2010) Ronald P. Taylor et al. SEMINARS IN HEMATOLOGY
- Rituximab inhibits B-cell receptor signaling
- (2009) S. Kheirallah et al. BLOOD
- The microenvironment in mature B-cell malignancies: a target for new treatment strategies
- (2009) J. A. Burger et al. BLOOD
- Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting
- (2009) Antonina V. Kurtova et al. BLOOD
- CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival
- (2009) A. Zucchetto et al. CANCER RESEARCH
- Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG
- (2009) A. K. Ghosh et al. CLINICAL CANCER RESEARCH
- Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions
- (2009) M. I. Vega et al. CLINICAL CANCER RESEARCH
- The role of natalizumab in hematopoietic stem cell mobilization
- (2009) Frank Neumann et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
- (2008) Z. Zeng et al. BLOOD
- CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential
- (2008) Tait D. Shanafelt et al. BRITISH JOURNAL OF HAEMATOLOGY
- R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study
- (2008) A. Martin et al. HAEMATOLOGICA
- CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia
- (2008) D. Rossi et al. HAEMATOLOGICA
- Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
- (2008) M. Krumbholz et al. NEUROLOGY
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD38 at the junction between prognostic marker and therapeutic target
- (2008) Silvia Deaglio et al. TRENDS IN MOLECULAR MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now